{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:37:49Z","timestamp":1768423069042,"version":"3.49.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Clinical Key Specialty","award":["KY20242050"],"award-info":[{"award-number":["KY20242050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02827-9","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:39:24Z","timestamp":1765431564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Liqin","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"5","key":"2827_CR1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular Disease, high blood pressure Research, clinical Cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050\u201365.","journal-title":"Hypertension"},{"issue":"1","key":"2827_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, et al. Chronic kidney disease. Nat Rev Dis Primers. 2025;11(1):8.","journal-title":"Nat Rev Dis Primers"},{"issue":"23","key":"2827_CR3","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","volume":"46","author":"K Marx-Sch\u00fctt","year":"2025","unstructured":"Marx-Sch\u00fctt K, Cherney DZI, Jankowski J, Matsushita K, Nardone M, Marx N. Cardiovascular disease in chronic kidney disease. Eur Heart J. 2025;46(23):2148\u201360.","journal-title":"Eur Heart J"},{"issue":"3","key":"2827_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1381612824666180110102125","volume":"24","author":"Z Matloch","year":"2018","unstructured":"Matloch Z, Cinkajzlova A, Mraz M, Haluzik M. The role of inflammation in epicardial adipose tissue in heart diseases. Curr Pharm Des. 2018;24(3):297\u2013309.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"2827_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrendo.2015.58","volume":"11","author":"G Iacobellis","year":"2015","unstructured":"Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11(6):363\u201371.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2827_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","volume":"22","author":"G Iacobellis","year":"2011","unstructured":"Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metabolism. 2011;22(11):450\u20137.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"12","key":"2827_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","volume":"22","author":"G Iacobellis","year":"2009","unstructured":"Iacobellis G, Willens HJ. Echocardiographic epicardial fat: A review of research and clinical applications. J Am Soc Echocardiogr. 2009;22(12):1311\u20139.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"2827_CR8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/jcm11051308","volume":"11","author":"K Turkmen","year":"2022","unstructured":"Turkmen K, Ozer H, Kusztal M. The relationship of epicardial adipose tissue and cardiovascular disease in chronic kidney disease and Hemodialysis patients. J Clin Med. 2022;11(5):1308.","journal-title":"Journal of clinical medicine"},{"issue":"9","key":"2827_CR9","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1210\/jc.2009-0571","volume":"94","author":"HS Sacks","year":"2009","unstructured":"Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Uncoupling Protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metabolism. 2009;94(9):3611\u20135.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"9","key":"2827_CR10","doi-asserted-by":"publisher","first-page":"E1448","DOI":"10.1210\/jc.2013-1265","volume":"98","author":"HS Sacks","year":"2013","unstructured":"Sacks HS, Fain JN, Bahouth SW, Ojha S, Frontini A, Budge H, et al. Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab. 2013;98(9):E1448\u201355.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2827_CR11","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/oby.24023","volume":"32","author":"E Doukbi","year":"2024","unstructured":"Doukbi E, Ancel P, Dutour A, Soghomonian A, Ahmed S, Castejon V, et al. Human epicardial fat has a beige profile and contains higher type 2 innate lymphoid cells than subcutaneous fat. Obesity. 2024;32(7):1302\u201314.","journal-title":"Obesity"},{"issue":"1","key":"2827_CR12","doi-asserted-by":"publisher","first-page":"15566","DOI":"10.1038\/s41598-017-15501-7","volume":"7","author":"K Chechi","year":"2017","unstructured":"Chechi K, Voisine P, Mathieu P, Laplante M, Bonnet S, Picard F, et al. Functional characterization of the Ucp1-associated oxidative phenotype of human epicardial adipose tissue. Sci Rep. 2017;7(1):15566.","journal-title":"Sci Rep"},{"issue":"2","key":"2827_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/met.2008.0056","volume":"7","author":"M Pezeshkian","year":"2009","unstructured":"Pezeshkian M, Noori M, Najjarpour-Jabbari H, Abolfathi A, Darabi M, Darabi M, et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord. 2009;7(2):125\u201331.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2827_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14797\/mdcj-13-1-20","volume":"13","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhang A, Hamilton DJ, Deng T. Epicardial fat in the maintenance of cardiovascular health. Methodist Debakey Cardiovasc J. 2017;13(1):20\u20134.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"3","key":"2827_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/ijms21030978","volume":"21","author":"L D'Marco","year":"2020","unstructured":"D\u2019Marco L, Puchades MJ, Gorriz JL, Romero-Parra M, Lima-Martinez M, Soto C et al. Epicardial adipose Tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease. Int J Mol Sci. 2020;21(3):978.","journal-title":"International journal of molecular sciences"},{"issue":"20","key":"2827_CR16","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460\u20136.","journal-title":"Circulation"},{"key":"2827_CR17","doi-asserted-by":"crossref","unstructured":"Engin A. Adiponectin-Resistance in Obesity. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology. 2017;960:415\u201341.","DOI":"10.1007\/978-3-319-48382-5_18"},{"issue":"3","key":"2827_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/jcm8030299","volume":"8","author":"NR Aeddula","year":"2019","unstructured":"Aeddula NR, Cheungpasitporn W, Thongprayoon C, Pathireddy S. Epicardial adipose tissue and renal disease. J Clin Med. 2019;8(3):299.","journal-title":"J Clin Med"},{"key":"2827_CR19","doi-asserted-by":"crossref","unstructured":"Fang H, Judd RL. Adiponectin Regulation and Function. Compr Physiol. 2018;8(3):1031\u201363.","DOI":"10.1002\/j.2040-4603.2018.tb00036.x"},{"key":"2827_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1291537","volume":"2016","author":"J Salazar","year":"2016","unstructured":"Salazar J, Luzardo E, Mej\u00edas JC, Rojas J, Ferreira A, Rivas-R\u00edos JR, et al. Epicardial fat: Physiological, Pathological, and therapeutic implications. Cardiol Res Pract. 2016;2016:1\u201315.","journal-title":"Cardiol Res Pract"},{"issue":"9","key":"2827_CR21","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","volume":"55","author":"AT Turer","year":"2012","unstructured":"Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319\u201326.","journal-title":"Diabetologia"},{"issue":"1","key":"2827_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrcardio.2009.224","volume":"7","author":"G Sweeney","year":"2010","unstructured":"Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol. 2010;7(1):22\u20139.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"2827_CR23","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","volume":"62","author":"J Van de Voorde","year":"2013","unstructured":"Van de Voorde J, Pauwels B, Boydens C, Decaluw\u00e9 K. Adipocytokines in relation to cardiovascular disease. Metabolism. 2013;62(11):1513\u201321.","journal-title":"Metabolism"},{"issue":"11","key":"2827_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","volume":"118","author":"JJ Fuster","year":"2016","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-Induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circul Res. 2016;118(11):1786\u2013807.","journal-title":"Circul Res"},{"issue":"10","key":"2827_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"2827_CR26","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11255-020-02575-y","volume":"52","author":"G Song","year":"2020","unstructured":"Song G, Qiao W, Liu K, Yu X. Epicardial adipose tissue in patients with chronic kidney disease: a meta-analysis study and trial sequential analysis. Int Urol Nephrol. 2020;52(12):2345\u201355.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2827_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang PM-K, Nikolic-Paterson DJ, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144\u201358.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2827_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41581-018-0097-0","volume":"15","author":"C Kurts","year":"2019","unstructured":"Kurts C, Meyer-Schwesinger C. Protecting the kidney against autoimmunity and inflammation. Nat Rev Nephrol. 2019;15(2):66\u20138.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2827_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ndt\/gfs350","volume":"28","author":"K Jin","year":"2013","unstructured":"Jin K, Norris K, Vaziri ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dialysis Transplantation. 2013;28(2):313\u201320.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"2827_CR30","doi-asserted-by":"crossref","unstructured":"Opazo-R\u00edos L, Mas S, Mar\u00edn-Royo G, Mezzano S, G\u00f3mez-Guerrero C, Moreno JA et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2020;21(7):2632.","DOI":"10.3390\/ijms21072632"},{"issue":"5","key":"2827_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4093\/dmj.2023.0067","volume":"47","author":"SH Suh","year":"2023","unstructured":"Suh SH, Kim SW. Dyslipidemia in patients with chronic kidney disease: an updated overview. Diabetes Metab J. 2023;47(5):612\u201329.","journal-title":"Diabetes Metab J"},{"issue":"5","key":"2827_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jacl.2020.07.011","volume":"14","author":"K Yamatani","year":"2020","unstructured":"Yamatani K, Hirayama S, Seino U, Hirayama A, Hori A, Suzuki K, et al. Pre\u03b21-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on Hemodialysis. J Clin Lipidol. 2020;14(5):730\u20139.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"2827_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/joim.12290","volume":"277","author":"L Calabresi","year":"2015","unstructured":"Calabresi L, Simonelli S, Conca P, Busnach G, Cabibbe M, Gesualdo L, et al. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in Lowering plasma HDL levels in chronic kidney disease. J Intern Med. 2015;277(5):552\u201361.","journal-title":"J Intern Med"},{"issue":"3","key":"2827_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/biof.1205","volume":"41","author":"R Namiri-Kalantari","year":"2015","unstructured":"Namiri-Kalantari R, Gao F, Chattopadhyay A, Wheeler AA, Navab KD, Farias-Eisner R, et al. The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory. BioFactors. 2015;41(3):153\u20139.","journal-title":"BioFactors"},{"key":"2827_CR35","doi-asserted-by":"crossref","unstructured":"Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J. Dietary lipids and dyslipidemia in chronic kidney disease. Nutrients. 2021;13(9):3138.","DOI":"10.3390\/nu13093138"},{"issue":"1","key":"2827_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2015.180","volume":"12","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2016;12(1):37\u201347.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2827_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12882-018-0814-8","volume":"19","author":"R Kaseda","year":"2018","unstructured":"Kaseda R, Tsuchida Y, Yang HC, Yancey PG, Zhong J, Tao H, et al. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism. BMC Nephrol. 2018;19(1):17.","journal-title":"BMC Nephrol"},{"key":"2827_CR38","doi-asserted-by":"crossref","unstructured":"Berm\u00fadez V, Dur\u00e1n P, Rojas E, D\u00edaz MP, Rivas J, Nava M et al. The sick adipose tissue: new insights into defective signaling and crosstalk with the myocardium. Front Endocrinol. 2021;12:735070.","DOI":"10.3389\/fendo.2021.735070"},{"key":"2827_CR39","doi-asserted-by":"crossref","unstructured":"Bhullar SK, Dhalla NS. Angiotensin II-Induced signal transduction mechanisms for cardiac hypertrophy. Cells. 2022;11(21):3336.","DOI":"10.3390\/cells11213336"},{"issue":"Pt A","key":"2827_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","volume":"125","author":"T Kawai","year":"2017","unstructured":"Kawai T, Forrester SJ, O\u2019Brien S, Baggett A, Rizzo V, Eguchi S. AT1 receptor signaling pathways in the cardiovascular system. Pharmacol Res. 2017;125(Pt A):4\u201313.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2827_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","volume":"5","author":"VB Patel","year":"2016","unstructured":"Patel VB, Basu R, Oudit GY. ACE2\/Ang 1\u20137 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte. 2016;5(3):306\u201311.","journal-title":"Adipocyte"},{"issue":"3","key":"2827_CR42","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98(3):1627\u2013738.","journal-title":"Physiol Rev"},{"issue":"2","key":"2827_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10741-019-09837-7","volume":"25","author":"A Mascolo","year":"2020","unstructured":"Mascolo A, Urbanek K, De Angelis A, Sessa M, Scavone C, Berrino L, et al. Angiotensin II and angiotensin 1\u20137: which is their role in atrial fibrillation? Heart Fail Rev. 2020;25(2):367\u201380.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2827_CR44","doi-asserted-by":"publisher","first-page":"e13280","DOI":"10.1111\/apha.13280","volume":"227","author":"C Sumners","year":"2019","unstructured":"Sumners C, Peluso AA, Haugaard AH, Bertelsen JB, Steckelings UM. Anti-fibrotic mechanisms of angiotensin AT(2) -receptor stimulation. Acta Physiol (Oxf). 2019;227(1):e13280.","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"2827_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10741-020-09997-x","volume":"27","author":"Y Song","year":"2022","unstructured":"Song Y, Song F, Wu C, Hong YX, Li G. The roles of epicardial adipose tissue in heart failure. Heart Fail Rev. 2022;27(1):369\u201377.","journal-title":"Heart Fail Rev"},{"issue":"10","key":"2827_CR46","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.3390\/toxins7103933","volume":"7","author":"O Deltombe","year":"2015","unstructured":"Deltombe O, Van Biesen W, Glorieux G, Massy Z, Dhondt A, Eloot S. Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during Hemodialysis. Toxins (Basel). 2015;7(10):3933\u201346.","journal-title":"Toxins (Basel)"},{"issue":"5","key":"2827_CR47","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G, Argil\u00e9s A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934\u201343.","journal-title":"Kidney Int"},{"key":"2827_CR48","doi-asserted-by":"crossref","unstructured":"Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: A comprehensive update. Toxins (Basel). 2018;10(1):33.","DOI":"10.3390\/toxins10010033"},{"issue":"7","key":"2827_CR49","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","volume":"403","author":"Y Itoh","year":"2012","unstructured":"Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T. Protein-bound uremic toxins in Hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem. 2012;403(7):1841\u201350.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"2827_CR50","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/09168451.2020.1715782","volume":"84","author":"S Tsutsumi","year":"2020","unstructured":"Tsutsumi S, Tokunaga Y, Shimizu S, Kinoshita H, Ono M, Kurogi K, et al. Investigation of the effects of indoxyl sulfate, a uremic toxin, on the intracellular oxidation level and phagocytic activity using an HL-60-differentiated human macrophage cell model. Biosci Biotechnol Biochem. 2020;84(5):1023\u20139.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"2827_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","volume":"139","author":"T Nakano","year":"2019","unstructured":"Nakano T, Katsuki S, Chen M, Decano JL, Halu A, Lee LH, et al. Uremic toxin indoxyl sulfate promotes Proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch signaling. Circulation. 2019;139(1):78\u201396.","journal-title":"Circulation"},{"issue":"1","key":"2827_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2014121241","volume":"27","author":"S Shivanna","year":"2016","unstructured":"Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, et al. The Aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia. J Am Soc Nephrol. 2016;27(1):189\u2013201.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2827_CR53","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.kint.2017.11.010","volume":"93","author":"L Dou","year":"2018","unstructured":"Dou L, Poitevin S, Sallee M, Addi T, Gondouin B, McKay N, et al. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease. Kidney Int. 2018;93(4):986\u201399.","journal-title":"Kidney Int"},{"key":"2827_CR54","doi-asserted-by":"crossref","unstructured":"Arinze NV, Yin W, Lotfollahzadeh S, Napoleon MA, Richards S, Walker JA et al. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. J Clin Invest. 2022;132(1):e142260.","DOI":"10.1172\/JCI142260"},{"key":"2827_CR55","doi-asserted-by":"crossref","unstructured":"Wakamatsu T, Yamamoto S, Ito T, Sato Y, Matsuo K, Takahashi Y et al. Indoxyl sulfate promotes macrophage IL-1beta production by activating Aryl hydrocarbon Receptor\/NF-kappa\/MAPK Cascades, but the NLRP3 inflammasome was not activated. Toxins (Basel). 2018;10(3):124.","DOI":"10.3390\/toxins10030124"},{"key":"2827_CR56","doi-asserted-by":"publisher","first-page":"116570","DOI":"10.1016\/j.lfs.2019.116570","volume":"231","author":"T He","year":"2019","unstructured":"He T, Xiong J, Huang Y, Zheng C, Liu Y, Bi X, et al. Klotho restrain RIG-1\/NF-kappaB signaling activation and monocyte inflammatory factor release under uremic condition. Life Sci. 2019;231:116570.","journal-title":"Life Sci"},{"key":"2827_CR57","doi-asserted-by":"crossref","unstructured":"Harlacher E, Wollenhaupt J, Baaten C, Noels H. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: A systematic review. Int J Mol Sci. 2022;23(1):531.","DOI":"10.3390\/ijms23010531"},{"issue":"1","key":"2827_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2369-14-56","volume":"14","author":"D Bolati","year":"2013","unstructured":"Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-\u03baB. BMC Nephrol. 2013;14(1):56.","journal-title":"BMC Nephrol"},{"key":"2827_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys BD. Mechanisms of renal fibrosis. Annu Rev Physiol. 2018;80:309\u201326.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"2827_CR60","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41467-020-16158-z","volume":"11","author":"F Liu","year":"2020","unstructured":"Liu F, Dai S, Feng D, Qin Z, Peng X, Sakamuri SSVP, et al. Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat Commun. 2020;11(1):2280.","journal-title":"Nat Commun"},{"key":"2827_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-3-031-63657-8_15","volume":"1460","author":"A Engin","year":"2024","unstructured":"Engin A. Adiponectin resistance in obesity: adiponectin Leptin\/Insulin interaction. Adv Exp Med Biol. 2024;1460:431\u201362.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2827_CR62","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","volume":"34","author":"K Daenen","year":"2018","unstructured":"Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B. Oxidative stress in chronic kidney disease. Pediatr Nephrol. 2018;34(6):975\u201391.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2827_CR63","doi-asserted-by":"publisher","first-page":"e0149276","DOI":"10.1371\/journal.pone.0149276","volume":"11","author":"C Barisione","year":"2016","unstructured":"Barisione C, Garibaldi S, Furfaro AL, Nitti M, Palmieri D, Passalacqua M, et al. Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages. PLoS ONE. 2016;11(2):e0149276.","journal-title":"PLoS ONE"},{"key":"2827_CR64","doi-asserted-by":"crossref","unstructured":"Yang HS, Kim SN, Ro JH, Hur M. Adiponectin and All-Cause mortality in patients with chronic kidney disease: A systematic review and Meta-Analysis. Metabolites. 2025;15(4):230.","DOI":"10.3390\/metabo15040230"},{"key":"2827_CR65","doi-asserted-by":"crossref","unstructured":"Korczynska J, Czumaj A, Chmielewski M, Swierczynski J, Sledzinski T. The causes and potential injurious effects of elevated serum leptin levels in chronic kidney disease patients. Int J Mol Sci. 2021;22(9):4685.","DOI":"10.3390\/ijms22094685"},{"key":"2827_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue Distribution, inflammation and its metabolic Consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2827_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000503416","volume":"10","author":"J Munjas","year":"2020","unstructured":"Munjas J, Sopi\u0107 M, Bogavac-Stanojevi\u0107 N, Kravlja\u010da M, Miljkovi\u0107 M, Simi\u0107-Ogrizovi\u0107 S, et al. Serum Resistin, adenylate Cyclase-Associated protein 1 gene Expression, and carotid Intima-Media thickness in patients with End-Stage renal disease and healthy controls. Cardiorenal Med. 2020;10(1):51\u201360.","journal-title":"Cardiorenal Med"},{"issue":"12","key":"2827_CR68","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1440-1681.2011.05601.x","volume":"38","author":"HS Sacks","year":"2011","unstructured":"Sacks HS, Fain JN. Human epicardial fat: what is new and what is missing? Clin Exp Pharmacol Physiol. 2011;38(12):879\u201387.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2827_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-5-1","volume":"5","author":"AR Baker","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2827_CR70","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/oby.2008.379","volume":"16","author":"A Silaghi","year":"2008","unstructured":"Silaghi A, Piercecchi-Marti MD, Grino M, Leonetti G, Alessi MC, Clement K, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obes (Silver Spring). 2008;16(11):2424\u201330.","journal-title":"Obes (Silver Spring)"},{"issue":"12","key":"2827_CR71","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.amjcard.2008.08.010","volume":"102","author":"R Djaberi","year":"2008","unstructured":"Djaberi R, Schuijf JD, van Werkhoven JM, Nucifora G, Jukema JW, Bax JJ. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol. 2008;102(12):1602\u20137.","journal-title":"Am J Cardiol"},{"issue":"7","key":"2827_CR72","first-page":"545","volume":"124","author":"E Con","year":"2023","unstructured":"Con E, Yilmaz A, Suygun H, Mustu M, Karadeniz FO, Kilic O, et al. The relationship between epicardial adipose tissue thickness and coronary artery disease progress. Bratisl Lek Listy. 2023;124(7):545\u20138.","journal-title":"Bratisl Lek Listy"},{"issue":"6","key":"2827_CR73","doi-asserted-by":"publisher","first-page":"388","DOI":"10.6061\/clinics\/2014(06)04","volume":"69","author":"MB Demircelik","year":"2014","unstructured":"Demircelik MB, Yilmaz OC, Gurel OM, Selcoki Y, Atar IA, Bozkurt A, et al. Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clin (Sao Paulo). 2014;69(6):388\u201392.","journal-title":"Clin (Sao Paulo)"},{"issue":"1","key":"2827_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14503\/THIJ-14-4850","volume":"43","author":"AF Erkan","year":"2016","unstructured":"Erkan AF, Tanindi A, Kocaman SA, Ugurlu M, Tore HF. Epicardial adipose tissue thickness is an independent predictor of critical and complex coronary artery disease by Gensini and syntax scores. Tex Heart Inst J. 2016;43(1):29\u201337.","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"2827_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ihj.2015.08.005","volume":"68","author":"K Meenakshi","year":"2016","unstructured":"Meenakshi K, Rajendran M, Srikumar S, Chidambaram S. Epicardial fat thickness: A surrogate marker of coronary artery disease - Assessment by echocardiography. Indian Heart J. 2016;68(3):336\u201341.","journal-title":"Indian Heart J"},{"issue":"10","key":"2827_CR76","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.echo.2015.07.006","volume":"28","author":"Y Hirata","year":"2015","unstructured":"Hirata Y, Yamada H, Kusunose K, Iwase T, Nishio S, Hayashi S, et al. Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a High-Frequency linear probe in patients with coronary artery disease. J Am Soc Echocardiogr. 2015;28(10):1240\u20136. e1.","journal-title":"J Am Soc Echocardiogr"},{"key":"2827_CR77","doi-asserted-by":"publisher","first-page":"117338","DOI":"10.1016\/j.lfs.2020.117338","volume":"245","author":"S Tong","year":"2020","unstructured":"Tong S, Du Y, Ji Q, Dong R, Cao J, Wang Z, et al. Expression of Sfrp5\/Wnt5a in human epicardial adipose tissue and their relationship with coronary artery disease. Life Sci. 2020;245:117338.","journal-title":"Life Sci"},{"issue":"2","key":"2827_CR78","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.atherosclerosis.2011.12.018","volume":"221","author":"R Nakazato","year":"2012","unstructured":"Nakazato R, Dey D, Cheng VY, Gransar H, Slomka PJ, Hayes SW, et al. Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis. 2012;221(2):422\u20136.","journal-title":"Atherosclerosis"},{"issue":"5","key":"2827_CR79","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ehjci\/jex314","volume":"19","author":"J Mancio","year":"2018","unstructured":"Mancio J, Azevedo D, Saraiva F, Azevedo AI, Pires-Morais G, Leite-Moreira A, et al. Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2018;19(5):490\u20137.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"2827_CR80","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696\u2013707.","journal-title":"Nat Rev Nephrol"},{"key":"2827_CR81","doi-asserted-by":"publisher","first-page":"924646","DOI":"10.3389\/fcvm.2022.924646","volume":"9","author":"Y Shao","year":"2022","unstructured":"Shao Y, Chen L, Chen W, Sang C, Xu C, Zhang C. Left atrial epicardial adipose tissue is associated with low voltage zones in the left atrium in patients with non-valvular atrial fibrillation. Front Cardiovasc Med. 2022;9:924646.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2827_CR82","doi-asserted-by":"publisher","first-page":"E164","DOI":"10.1152\/ajpendo.00374.2019","volume":"318","author":"AA Babakr","year":"2020","unstructured":"Babakr AA, Fomison-Nurse IC, van Hout I, Aitken-Buck HM, Sugunesegran R, Davis PJ, et al. Acute interaction between human epicardial adipose tissue and human atrial myocardium induces arrhythmic susceptibility. Am J Physiol Endocrinol Metab. 2020;318(2):E164\u201372.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2827_CR83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ehf2.12409","volume":"6","author":"J Zeller","year":"2019","unstructured":"Zeller J, Kruger C, Lamounier-Zepter V, Sag S, Strack C, Mohr M, et al. The adipo-fibrokine activin A is associated with metabolic abnormalities and left ventricular diastolic dysfunction in obese patients. ESC Heart Fail. 2019;6(2):362\u201370.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2827_CR84","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1038\/s41598-018-21911-y","volume":"8","author":"Q Wang","year":"2018","unstructured":"Wang Q, Xi W, Yin L, Wang J, Shen H, Gao Y, et al. Human epicardial adipose tissue cTGF expression is an independent risk factor for atrial fibrillation and highly associated with atrial fibrosis. Sci Rep. 2018;8(1):3585.","journal-title":"Sci Rep"},{"issue":"10","key":"2827_CR85","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","volume":"76","author":"CJ Nalliah","year":"2020","unstructured":"Nalliah CJ, Bell JR, Raaijmakers AJA, Waddell HM, Wells SP, Bernasochi GB, et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality. J Am Coll Cardiol. 2020;76(10):1197\u2013211.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2827_CR86","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.hrthm.2022.05.011","volume":"19","author":"AC Ernault","year":"2022","unstructured":"Ernault AC, Verkerk AO, Bayer JD, Aras K, Montanes-Agudo P, Mohan RA, et al. Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling. Heart Rhythm. 2022;19(9):1461\u201370.","journal-title":"Heart Rhythm"},{"issue":"5","key":"2827_CR87","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","volume":"118","author":"AS Antonopoulos","year":"2016","unstructured":"Antonopoulos AS, Margaritis M, Verheule S, Recalde A, Sanna F, Herdman L, et al. Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-gamma\/Adiponectin signalling. Circ Res. 2016;118(5):842\u201355.","journal-title":"Circ Res"},{"issue":"11","key":"2827_CR88","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1080\/03007995.2018.1462786","volume":"34","author":"CA Goudis","year":"2018","unstructured":"Goudis CA, Vasileiadis IE, Liu T. Epicardial adipose tissue and atrial fibrillation: pathophysiological mechanisms, clinical implications, and potential therapies. Curr Med Res Opin. 2018;34(11):1933\u201343.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2827_CR89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4093\/dmj.2023.0190","volume":"48","author":"DH Cho","year":"2024","unstructured":"Cho DH, Park SM. Epicardial adipose tissue and heart Failure, friend or foe? Diabetes Metab J. 2024;48(3):373\u201384.","journal-title":"Diabetes Metab J"},{"key":"2827_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2019.02.023","volume":"284","author":"G Iacobellis","year":"2019","unstructured":"Iacobellis G, Mahabadi AA. Is epicardial fat Attenuation a novel marker of coronary inflammation? Atherosclerosis. 2019;284:212\u20133.","journal-title":"Atherosclerosis"},{"issue":"9","key":"2827_CR91","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593\u2013606.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"2827_CR92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/oby.2003.45","volume":"11","author":"G Iacobellis","year":"2003","unstructured":"Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11(2):304\u201310.","journal-title":"Obes Res"},{"issue":"6","key":"2827_CR93","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.amjcard.2008.04.058","volume":"102","author":"S Sarin","year":"2008","unstructured":"Sarin S, Wenger C, Marwaha A, Qureshi A, Go BDM, Woomert CA, et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol. 2008;102(6):767\u201371.","journal-title":"Am J Cardiol"},{"issue":"6","key":"2827_CR94","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jcmg.2022.11.018","volume":"16","author":"HW West","year":"2023","unstructured":"West HW, Siddique M, Williams MC, Volpe L, Desai R, Lyasheva M, et al. Deep-Learning for epicardial adipose tissue assessment with computed tomography: implications for cardiovascular risk prediction. JACC Cardiovasc Imaging. 2023;16(6):800\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"2827_CR95","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s00330-022-09257-6","volume":"33","author":"F Risch","year":"2023","unstructured":"Risch F, Schwarz F, Braun F, Bette S, Becker J, Scheurig-Muenkler C, et al. Assessment of epicardial adipose tissue on virtual non-contrast images derived from photon-counting detector coronary CTA datasets. Eur Radiol. 2023;33(4):2450\u201360.","journal-title":"Eur Radiol"},{"issue":"7","key":"2827_CR96","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/clc.23644","volume":"44","author":"G van Woerden","year":"2021","unstructured":"van Woerden G, van Veldhuisen DJ, Gorter TM, van Empel VPM, Hemels MEW, Hazebroek EJ, et al. Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction. Clin Cardiol. 2021;44(7):987\u201393.","journal-title":"Clin Cardiol"},{"issue":"1","key":"2827_CR97","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/joim.12344","volume":"278","author":"AC Cordeiro","year":"2015","unstructured":"Cordeiro AC, Amparo FC, Oliveira MA, Amodeo C, Smanio P, Pinto IM, et al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3\u20135 chronic kidney disease. J Intern Med. 2015;278(1):77\u201387.","journal-title":"J Intern Med"},{"key":"2827_CR98","doi-asserted-by":"publisher","first-page":"1547007","DOI":"10.3389\/fmed.2025.1547007","volume":"12","author":"S Feng","year":"2025","unstructured":"Feng S, Lai Z, Xue M, Zhu W, Zhou Q, Ke X, et al. The impact of perivascular adipose tissue characteristics on incident cardiovascular events in non-dialysis chronic kidney disease patients. Front Med (Lausanne). 2025;12:1547007.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2827_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/hdi.12091","volume":"18","author":"A Atakan","year":"2014","unstructured":"Atakan A, Macunluoglu B, Kaya Y, Ari E, Demir H, Asicioglu E, et al. Epicardial fat thickness is associated with impaired coronary flow reserve in Hemodialysis patients. Hemodial Int. 2014;18(1):62\u20139.","journal-title":"Hemodial Int"},{"issue":"10","key":"2827_CR100","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/ndt\/gft264","volume":"28","author":"LG D\u2019Marco","year":"2013","unstructured":"D\u2019Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P. Epicardial adipose tissue predicts mortality in incident Hemodialysis patients: a substudy of the renagel in new Dialysis trial. Nephrol Dialysis Transplantation. 2013;28(10):2586\u201395.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"1","key":"2827_CR101","doi-asserted-by":"publisher","first-page":"23090","DOI":"10.1038\/s41598-021-02427-4","volume":"11","author":"SS Kwon","year":"2021","unstructured":"Kwon SS, Choi K, Da Nam B, Lee H, Cho NJ, Park BW, et al. Epicardial adipose tissue radiodensity is associated with all-cause mortality in patients undergoing Hemodialysis. Sci Rep. 2021;11(1):23090.","journal-title":"Sci Rep"},{"issue":"2","key":"2827_CR102","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40620-015-0221-1","volume":"29","author":"X Barros","year":"2016","unstructured":"Barros X, Dirrichs T, Koos R, Reinartz S, Kaesler N, Kramann R, et al. Epicardial adipose tissue in long-term Hemodialysis patients: its association with vascular calcification and long-term development. J Nephrol. 2016;29(2):241\u201350.","journal-title":"J Nephrol"},{"issue":"2","key":"2827_CR103","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1507\/endocrj.EJ24-0377","volume":"72","author":"J Zhou","year":"2025","unstructured":"Zhou J, Gao X, Zhang D, Jiang C, Yu W. Effects of breaking up prolonged sitting via exercise snacks intervention on the body composition and plasma metabolomics of sedentary obese adults: a randomized controlled trial. Endocr J. 2025;72(2):183\u201392.","journal-title":"Endocr J"},{"key":"2827_CR104","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","volume":"274","author":"V Parisi","year":"2019","unstructured":"Parisi V, Petraglia L, D\u2019Esposito V, Cabaro S, Rengo G, Caruso A, et al. Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue. Int J Cardiol. 2019;274:326\u201330.","journal-title":"Int J Cardiol"},{"issue":"12","key":"2827_CR105","doi-asserted-by":"publisher","first-page":"e013104","DOI":"10.1161\/JAHA.119.013104","volume":"8","author":"P Raggi","year":"2019","unstructured":"Raggi P, Gadiyaram V, Zhang C, Chen Z, Lopaschuk G, Stillman AE. Statins reduce epicardial adipose tissue Attenuation independent of lipid lowering: A potential pleiotropic effect. J Am Heart Assoc. 2019;8(12):e013104.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2827_CR106","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.xcrm.2024.101614","volume":"5","author":"Q Fang","year":"2024","unstructured":"Fang Q, Lu X, Zhu Y, Lv X, Yu F, Ma X, et al. Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia. Cell Rep Med. 2024;5(6):101614.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2827_CR107","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1038\/s41598-024-57708-5","volume":"14","author":"H Sard\u00e0","year":"2024","unstructured":"Sard\u00e0 H, Colom C, Benitez S, Carreras G, Amig\u00f3 J, Mi\u00f1ambres I, et al. PCSK9 plasma concentration is associated with epicardial adipose tissue volume and metabolic control in patients with type 1 diabetes. Sci Rep. 2024;14(1):7195.","journal-title":"Sci Rep"},{"issue":"1","key":"2827_CR108","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","volume":"22","author":"VA Myasoedova","year":"2023","unstructured":"Myasoedova VA, Parisi V, Moschetta D, Valerio V, Conte M, Massaiu I, et al. Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):23.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02827-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02827-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02827-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:05:14Z","timestamp":1768392314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-025-02827-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02827-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}